Time is of the essence for a Brazilian neuroscientist who wants to study whale and dolphin brains before the brains decompose ...

Indian startups collectively secured approximately $375.52 million in funding, comprising 7 grow th-stage deals and 22 ...

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we ...

The Middle East and Africa (MEA) region is at the forefront of a global renewable energy transformation, and leading this ...

With this fresh capital, the Bengaluru-based company aims to accelerate its AI-driven product development and expand its ...

Its architect's daughter has cystic fibrosis—and benefits from a "miracle drug" backed by an agency he's attacking.

Pfizer announced Jeffrey Legos, PhD, MBA as its new chief oncology officer. Bluejay Therapeutics announced Mary Cromwell, PhD, has joined its leadership team as SVP and head of technical operations.

The daughter of a key architect of Project 2025 benefitted from a life-changing drug — which was created with the help of the ...

SpotDraft's Series B funding round, spearheaded by Vertex Ventures and Trident Partners, will accelerate the company's global ...

Biogen Inc. CEO Christopher Viehbacher gave investors an overview of what type of deals the company is looking for Wednesday ...

We are excited to collaborate with Biogen on litifilimab,” said Pablo Legorreta, Royalty Pharma’s founder and Chief Executive Officer. “Royalty Pharma offers tailored, win-win funding solutions for ...